{"adverse_reactions":["Sincerus Florida, LLC adverse reactions. p"],"components":["Active, Inactive h"],"effective_time":"20190424","id":"874c79d7-7767-3d66-e053-2995a90a6d5c","instructions_for_use":["Directions for use x"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1130-2 IVERMECTIN USP 1% / METRONIDAZOLE USP 1% gel 30 gm c"],"set_id":"874c79d7-7766-3d66-e053-2995a90a6d5c","spl_product_data_elements":["IVERMECTIN 1% / METRONIDAZOLE 1% IVERMECTIN 1% / METRONIDAZOLE 1% METRONIDAZOLE METRONIDAZOLE IVERMECTIN IVERMECTIN"],"version":"1"}